Affirming Primary Care¶
By two years post-transition the central medical question is no longer how to get hormones — it is who runs your chart for the next thirty years. The acute-transition era of IC-clinic prescribing and surgical milestones gives way to a maintenance era whose bottleneck is a primary-care physician (PCP) who holds the longitudinal record, orders labs, manages the cardiometabolic and bone-health drift of long-term estrogen, runs anatomy-appropriate cancer screening, and refers competently.
The UCSF Center of Excellence for Transgender Health Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People and WPATH SOC v8 Chapter 9 are the operating documents. They describe an integrated model: routine primary care delivered by a clinician fluent in gender-affirming pharmacology and screening, treating hormones as one prescription among many rather than the entire reason for the visit.
This page is a vetting framework. It does not endorse specific clinicians, clinics, or platforms. For mental-health vetting, see Finding a Therapist. For chart portability, see Healthcare Records. For directories, see Resources.
Scope
Vetting framework only. No specific PCP, clinic, or platform recommendations. Fit is local; affirming-clinician availability shifts with insurance changes, retirements, and political climate.
What "trans-affirming PCP" actually means¶
The term trans-affirming is overloaded. As with mental-health providers there is a hierarchy, and the difference between levels is the difference between competent maintenance care and frustrating, dysphoria-laden visits.
| Label | What it means in practice | Useful as a filter? |
|---|---|---|
| Trans-affirming | Trained in gender-affirming primary care; prescribes and monitors HRT directly; runs anatomy-appropriate screening; correct name and pronouns; gender as background context. Often GEI-certified. | Yes — the meaningful tier. |
| Trans-competent | Trans patients in panel; manages HRT but defers complex decisions; mostly correct on pronouns; may need correction on screening guidance. | Acceptable floor. Vet further. |
| Trans-aware / -friendly | Won't refuse you; visible effort; defaults to "endocrinology handles the hormones"; uncertain on post-surgical anatomy screening. | Low signal. |
| Trans-tolerant | Takes the appointment. Provides no special competence. | None. |
A PCP who refers all hormone management to endocrinology indefinitely is not practicing the UCSF/SOC-8 model — that model places routine HRT firmly in the primary-care scope after stabilization.
IC clinics versus independent PCPs for ongoing care¶
Informed-consent clinics (Plume, FOLX, QueerDoc, Planned Parenthood IC programs, Spektrum, regional equivalents) are excellent for HRT initiation and early titration. They are not a complete primary-care home. Most IC platforms scope themselves to gender-affirming hormone therapy; they do not run general primary care, manage hypertension or diabetes, handle acute illness, or perform in-person exams.
| Arrangement | Pros | Cons |
|---|---|---|
| IC clinic for HRT, independent PCP for everything else | Frictionless HRT; PCP chosen on independent merits | Two charts to reconcile; PCP is not the prescriber for your most consequential drug |
| Move HRT to PCP, drop the IC clinic | UCSF/SOC-8 ideal: one chart, one prescriber, integrated screening, insurance-billable | Requires a PCP who actually wants the prescription on their license and runs the labs |
| IC clinic as only medical home | Simple while it works | Cardiovascular risk, cancer screening, vaccines, acute care all fall through the gap |
The pragmatic two-year arc: vet and onboard an independent affirming PCP, verify they will own the HRT prescription and the lab cadence, then transfer prescribing off the IC clinic.
Where to start the search¶
No directory is sufficient on its own. Treat each as a filtered candidate pool. Plan to contact 4–8 candidates to land 1–2 first appointments.
| Source | What it gives you | Caveat |
|---|---|---|
| Advocates for Trans Equality (A4TE) directories | Community-vetted starting point | Inclusion is not vetted competence |
| WPATH provider directory | Clinicians with explicit WPATH alignment, often GEI-certified | Higher floor of competence; smaller pool |
| GLMA provider directory | LGBTQ-focused, skews toward physicians | Good for primary care specifically |
| Local LGBT center referrals | Lists vetted by ongoing community feedback | Highest-trust source if you live near a metro area |
| FQHCs with LGBT health programs | Howard Brown, Whitman-Walker, Fenway, Callen-Lorde, Mazzoni, Lyon-Martin, etc. | Sliding scale, deep affirming competence, in-house specialty referrals |
| Insurance plan directories | Necessary if using insurance | Notoriously stale; verify with the practice directly |
| Community word of mouth | Local trans groups, regional Discord/Reddit | High signal for fit; verify scope (HRT, letters, or full primary care?) |
A front desk that fumbles "do you take trans patients, prescribe HRT directly, and accept my insurance?" is a signal about practice culture.
Vetting questions for a first appointment¶
The goal is to assess scope of practice and framework, not to interview them on trans 101.
| Question | What an affirming answer looks like |
|---|---|
| About how many trans patients do you see, and over what period? | Ongoing experience, not one patient five years ago. |
| Do you prescribe and monitor HRT directly, or co-manage with endocrinology? | Prescribes directly after stabilization. Indefinite endo referral is a scope flag. |
| What lab cadence do you use for stable estradiol regimens? | Every 6–12 months once stable: estradiol, total T, lipids, fasting glucose/HbA1c, CBC, CMP, prolactin when indicated. |
| How do you handle PSA in a transfeminine patient on long-term estrogen? | Engages with the PSA-suppression effect of estrogen; uses an adjusted threshold rather than cis-male thresholds or skipping. |
| For a post-vaginoplasty patient, what's your role versus a gynecologist? | PCP can do neovaginal speculum exams if trained; refers to GYN with neovaginal experience for complex issues; manages routine. |
| What's your position on bone-density screening for transfeminine patients? | DEXA at 65 routinely; earlier with risk factors (post-orchi without consistent estrogen, steroids, low BMI, family history). |
| Do you write surgical letters? | Many affirming PCPs do under the SOC-8 primary-care-author model. Get this clear early if you may need letters. |
| How do you handle referrals to specialists who are skeptical of trans care? | Will call the specialist, rewrite the referral, back you up if a specialist behaves badly. |
Pay attention to whether they ask what you want from primary care, whether they use your name and pronouns naturally throughout the visit, and whether they treat the gender history as background context rather than the visit's central topic.
Red flags¶
Any one warrants caution; two or more usually warrants leaving.
- Refers all HRT management to endocrinology indefinitely. Inconsistent with UCSF and SOC-8 primary-care scope.
- Wants a psychiatric letter for refills of an established HRT regimen. No guideline supports this.
- Outdated terminology as default: transgendered, biological sex as the framing default, real name, preferred pronouns. A single slip is human; a pattern is a framework problem.
- Doesn't know the relevant screening adjustments: applies cis-male thresholds reflexively, skips prostate screening entirely, ignores post-orchiectomy bone-density risk.
- Treats every visit as a gender visit. Sore-throat appointments don't need a gender-history retread.
- Imposes opinions on transition decisions — pace, surgeries, identity. The PCP's role is medical, not editorial.
- Refuses to write letters under any circumstances despite SOC-8 explicitly listing primary-care authorship as appropriate.
- Practice-culture problems: deadnaming on the rooming sheet that doesn't get fixed after a complaint, intake forms that force binary sex, staff who visibly struggle every visit.
Endocrinology-only deflection
"I'll let endocrinology handle the hormones" indefinitely is the most common scope-failure pattern dressed up as deference. Affirming PCPs co-manage during initiation and own the prescription after stabilization. A clinician who never reclaims the script is not running the UCSF/SOC-8 model.
Handling skeptical specialists referred by your PCP¶
Your affirming PCP will sometimes refer you to specialists who are not. The specialist pool is smaller and more variable than primary care.
- Front-load gender context in writing. A short portal note before the appointment — name, pronouns, HRT regimen, surgical history, anatomy summary — saves awkward live discovery.
- Ask the PCP for a referral with explicit context. "Transfeminine patient on estradiol 4mg/d sublingual, status-post vaginoplasty, presenting with [issue]" sets the frame.
- Bring backup. A friend or partner shifts the dynamic. A recording, where one-party consent is legal, is stronger backup if you expect trouble.
- Know your exit. Leaving, rebooking with a different specialist, or asking the PCP for someone else are all reasonable.
- Report back. An affirming PCP will adjust the referral pattern if you tell them a specialist was hostile.
- Distinguish skepticism from competence gaps. An awkward but knowledgeable urologist beats a smooth-talking one who doesn't know PSA-on-estrogen.
The long-term care team¶
The post-stabilization team for a transfeminine adult typically looks like:
- PCP: anchor of the team. Owns HRT prescribing, routine labs, screening, vaccinations, acute care, mental-health coordination, referrals, letters.
- Endocrinology: useful during initiation and titration, dose changes around surgeries, and atypical cases (refractory levels, prolactinoma, thyroid comorbidity). After stabilization most patients can be handed off entirely to PCP. Keep one in the rolodex; do not necessarily keep regular visits.
- Gynecology: required after vaginoplasty for neovaginal exams, granulation tissue, prolapse, and STI workup. GYNs at surgical centers with vaginoplasty programs are usually the strongest match.
- Urology: relevant for retained prostate. Estrogen suppresses PSA, so cis-male thresholds undershoot — find a urologist who understands the adjusted threshold (roughly half the cis cutoff in the long-term-estrogen literature). Also relevant for post-vaginoplasty urethral concerns.
- Dermatology: hair-removal management, acne and skin changes during HRT shifts, scar management, melanoma surveillance on the standard schedule.
Optional additions: a trans-affirming therapist (see Finding a Therapist), pelvic-floor PT, audiologist or laryngologist for voice work, sleep medicine, registered dietitian.
Telehealth versus in-person for ongoing maintenance¶
Telehealth is well-suited to refill visits, lab review, titration discussion, and routine check-ins. SOC v8 endorses it as a legitimate primary-care modality. State licensure is the binding constraint: the PCP must be licensed in the state where you are physically located during the visit. The Interstate Medical Licensure Compact helps but does not cover all states or clinicians.
In-person visits are necessary for physical and pelvic exams, vaccinations, procedures, and anything needing palpation or auscultation. The reasonable default: a telehealth-first PCP within driving distance, so most visits are remote but in-person is available when needed. Pure telehealth without an in-person option strands you when something needs an exam.
When your PCP retires, moves, or leaves the practice¶
Plan for it. Affirming PCPs are scarce and turnover is real.
- Keep your records portable. Request a full chart download annually. Lab history, HRT prescribing history, surgical reports, and referral letters are the load-bearing documents. See Healthcare Records.
- Ask the departing clinician for warm handoffs. They often know which local clinicians are affirming and accepting patients. Highest-signal referral you'll get.
- Don't let the script run out. Get a 90-day fill before the last visit if insurance allows. Bridge with an IC clinic if you have to.
- Re-vet the replacement. Inheriting a panel does not mean inheriting the prior clinician's competence. Run the vetting questions from scratch.
Insurance and PCP changes¶
Insurance changes — new job, plan-year switches, marketplace shifts, Medicaid churn — frequently force PCP changes whether you want them or not.
- Check the in-network PCP list before accepting a plan. A plan that covers gender-affirming care on paper but has no affirming PCP in network is worse than the rate suggests.
- Verify network status with the practice directly. Provider directories are notoriously stale.
- Use COBRA or marketplace bridge plans to avoid coverage gaps during job transitions. HRT continuity is the priority.
- Document medical necessity in the chart. Notes citing UCSF and SOC-8 are the strongest appeal evidence when insurance disputes coverage.
- Watch for prior-authorization requirements. Estradiol formulations, spironolactone, and progesterone occasionally need PA. An affirming office knows the dance; a non-affirming one may let the PA expire.
The honest summary¶
Long-term transfeminine maintenance is a primary-care problem, not an endocrinology problem. UCSF and SOC v8 Chapter 9 describe a PCP-led model in which HRT is one prescription among many and the PCP runs screening, labs, and referrals against the patient's actual anatomy. Vet for a clinician who prescribes HRT on their own license, knows the screening adjustments for long-term-estrogen anatomy, refers competently, and treats gender as background. Migrate prescribing off the IC clinic when the PCP earns the trust. Keep records portable. Plan for the retirement, the move, and the insurance change before they happen — they will.
Sources¶
- UCSF Center of Excellence for Transgender Health. (2016, updated 2023). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd edition. Deutsch, M. B. (Ed.). University of California, San Francisco.
- Coleman E., Radix A. E., Bouman W. P., et al. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgender Health, 23(sup1). Chapter 9: Primary Care.
- Iwamoto S. J., T'Sjoen G., Safer J. D., et al. (2019). Letter to the Editor: Routine prostate cancer screening for transgender women. J Clin Endocrinol Metab, 104(11), 5485–5486. (PSA suppression by estrogen and adjusted thresholds.)
- Nik-Ahd F., Jarjour A., Figueiredo J., et al. (2023). Prostate cancer in transgender women in the Veterans Affairs health system, 2000–2022. JAMA, 329(21), 1877–1879.
- Rosen H. N., Hamnvik O.-P. R., Jaisamrarn U., et al. (2019). Bone densitometry in transgender and gender non-conforming individuals: 2019 ISCD official position. J Clin Densitometry, 22(4), 544–553.
- Advocates for Trans Equality (A4TE, formerly NCTE). Provider and resource directories. (Cited as a starting point, not endorsement.)
- WPATH provider directory; GLMA provider directory. (Cited as starting points, not endorsements.)